Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells.
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansSyndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and PrognosticationSpecific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migrationMolecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapiesSyndecan-1 and Its Expanding List of ContactsCharacterizing the neurite outgrowth inhibitory effect of Mani.Inhibition of PDGF-B induction and cell growth by syndecan-1 involves the ubiquitin and SUMO-1 ligase, ToporsThe niche factor syndecan-1 regulates the maintenance and proliferation of neural progenitor cells during mammalian cortical developmentMagnetic nanoparticle-based isolation of endocytic vesicles reveals a role of the heat shock protein GRP75 in macromolecular delivery.Sulforhodamine B restaining as a whole-cell label allows visualizing one more fluorochrome and its application in assaying protein nucleocytoplasmic distribution.Shed syndecan-1 translocates to the nucleus of cells delivering growth factors and inhibiting histone acetylation: a novel mechanism of tumor-host cross-talk.D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo.Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotypeHeparan sulfate in the nucleus and its control of cellular functions.Syndecan-4 Regulates Muscle Differentiation and Is Internalized from the Plasma Membrane during Myogenesis.Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells.Recent data concerning heparanase: focus on fibrosis, inflammation and cancer.Glycosaminoglycans: key players in cancer cell biology and treatment.The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumorsSyndecans as modulators and potential pharmacological targets in cancer progression.Heparanase mediates vascular endothelial growth factor gene transcription in high-glucose human retinal microvascular endothelial cells.Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity.Two promoters with distinct activities in different tissues drive the expression of heparanase in Xenopus.Dually modified transmembrane proteoglycans in development and disease.Molecular targets and signaling pathways regulated by nuclear translocation of syndecan-1.Syndecan-1 regulates adipogenesis: new insights in dedifferentiated liposarcoma tumorigenesis.
P2860
Q21710680-809382A2-4A6E-4545-8153-137FE86B8D56Q26784262-1FBF4AD0-C352-4E3F-8CBC-1CC93578B5DBQ27313760-2C79F483-EF6D-4DC4-9BE4-FDFBCF927879Q28079232-E3179B65-5211-4605-A94A-1AC80E785634Q28084514-680747AF-84E2-4918-B20A-8954B96CEE62Q30418920-BF7E926D-FA37-4A0A-8EC4-EC35BC80E009Q31086903-4EA47122-D88C-4962-8646-3E60F992C0A5Q31088269-183F2F1A-7AC2-4236-8E45-A40FCAE52FE9Q34067982-02D97703-E14C-4244-BCB1-DAB02BD15A3EQ34264226-337C09FC-F34C-4832-936D-7DF10BEA8FDEQ34958906-5A5E2F0C-A088-44AB-BD0C-CED66AEA633EQ35108319-32063B4B-071C-4F91-B685-5781E25C5098Q35182839-3245DFA0-B067-42CC-81D6-38A1272774D5Q35190552-8FF0C0F8-A0C4-4877-BF2B-C2A2A06A3D57Q35661948-5F9EB36F-F39C-48A2-895C-4C7E45692544Q35668839-462B7218-D61D-46C6-BE99-39D2F76404F4Q35836200-7764B37D-B4B1-4D60-B9EB-5777A96AC21DQ37983930-20A055C0-C4E9-425A-B4B6-F32B1E5BE6DEQ38078480-74983133-CA77-4DC3-93F0-1B1DCC6069E1Q38176008-62EC2278-02EE-4D28-8A58-F212294CFC56Q38189392-EBB0330A-4D1B-4292-8726-A84949EF7229Q38604996-94F04D77-FC63-46A7-9E5C-8E7CC297A172Q38902935-C3E57DB7-D54A-48DA-8B3F-79A49C95B400Q45331274-0859E1DC-6EAD-4CDE-AB24-16DCE51491D6Q47240245-EB436E43-99E0-4C02-AAB6-FC27DEE14DABQ47318797-1D6E50F7-3115-4D9E-80FF-2F1E977C4061Q51040058-F33A4713-9AF9-4AAB-9D17-471549616F8B
P2860
Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Syndecan-1 and FGF-2, but not ...... ei of mesenchymal tumor cells.
@ast
Syndecan-1 and FGF-2, but not ...... ei of mesenchymal tumor cells.
@en
type
label
Syndecan-1 and FGF-2, but not ...... ei of mesenchymal tumor cells.
@ast
Syndecan-1 and FGF-2, but not ...... ei of mesenchymal tumor cells.
@en
prefLabel
Syndecan-1 and FGF-2, but not ...... ei of mesenchymal tumor cells.
@ast
Syndecan-1 and FGF-2, but not ...... ei of mesenchymal tumor cells.
@en
P2093
P2860
P50
P1433
P1476
Syndecan-1 and FGF-2, but not ...... lei of mesenchymal tumor cells
@en
P2093
Carolin Mogler
Georgios Tzanakakis
Ilona Kovalszky
Katalin Dobra
Nina Wolmer
Péter Hollósi
P2860
P356
10.1371/JOURNAL.PONE.0007346
P407
P577
2009-10-05T00:00:00Z